54 related articles for article (PubMed ID: 28373167)
21. The anaphase-promoting complex works together with the SCF complex for proteolysis of the S-phase cyclin Clb6 during the transition from G1 to S phase.
Wu SY; Kuan VJ; Tzeng YW; Schuyler SC; Juang YL
Fungal Genet Biol; 2016 Jun; 91():6-19. PubMed ID: 26994663
[TBL] [Abstract][Full Text] [Related]
22. Substrate recognition by the Cdc20 and Cdh1 components of the anaphase-promoting complex.
Pfleger CM; Lee E; Kirschner MW
Genes Dev; 2001 Sep; 15(18):2396-407. PubMed ID: 11562349
[TBL] [Abstract][Full Text] [Related]
23. The anaphase-promoting complex/cyclosome is required for anaphase progression in multinucleated Ashbya gossypii cells.
Gladfelter AS; Sustreanu N; Hungerbuehler AK; Voegeli S; Galati V; Philippsen P
Eukaryot Cell; 2007 Feb; 6(2):182-97. PubMed ID: 17158735
[TBL] [Abstract][Full Text] [Related]
24. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
Tsao H; Goel V; Wu H; Yang G; Haluska FG
J Invest Dermatol; 2004 Feb; 122(2):337-41. PubMed ID: 15009714
[TBL] [Abstract][Full Text] [Related]
25. Discovery of a novel pan-RAF inhibitor with potent anti-tumor activity in preclinical models of BRAF
Hong SP; Ahn SK
Life Sci; 2017 Aug; 183():37-44. PubMed ID: 28645859
[TBL] [Abstract][Full Text] [Related]
26. Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth.
Lasorella A; Stegmüller J; Guardavaccaro D; Liu G; Carro MS; Rothschild G; de la Torre-Ubieta L; Pagano M; Bonni A; Iavarone A
Nature; 2006 Jul; 442(7101):471-4. PubMed ID: 16810178
[TBL] [Abstract][Full Text] [Related]
27. Id-1 promotes chromosomal instability through modification of APC/C activity during mitosis in response to microtubule disruption.
Wang X; Di K; Zhang X; Han HY; Wong YC; Leung SC; Ling MT
Oncogene; 2008 Jul; 27(32):4456-66. PubMed ID: 18372912
[TBL] [Abstract][Full Text] [Related]
28. Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma.
Ferrari de Andrade L; Ngiow SF; Stannard K; Rusakiewicz S; Kalimutho M; Khanna KK; Tey SK; Takeda K; Zitvogel L; Martinet L; Smyth MJ
Cancer Res; 2014 Dec; 74(24):7298-308. PubMed ID: 25351955
[TBL] [Abstract][Full Text] [Related]
29. The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1.
Pfleger CM; Kirschner MW
Genes Dev; 2000 Mar; 14(6):655-65. PubMed ID: 10733526
[TBL] [Abstract][Full Text] [Related]
30. Control of dTTP pool size by anaphase promoting complex/cyclosome is essential for the maintenance of genetic stability.
Ke PY; Kuo YY; Hu CM; Chang ZF
Genes Dev; 2005 Aug; 19(16):1920-33. PubMed ID: 16103219
[TBL] [Abstract][Full Text] [Related]
31. Small-molecule inhibitors of ERK-mediated immediate early gene expression and proliferation of melanoma cells expressing mutated BRaf.
Samadani R; Zhang J; Brophy A; Oashi T; Priyakumar UD; Raman EP; St John FJ; Jung KY; Fletcher S; Pozharski E; MacKerell AD; Shapiro P
Biochem J; 2015 May; 467(3):425-38. PubMed ID: 25695333
[TBL] [Abstract][Full Text] [Related]
32. Insights into the cellular mechanism of the yeast ubiquitin ligase APC/C-Cdh1 from the analysis of in vivo degrons.
Arnold L; Höckner S; Seufert W
Mol Biol Cell; 2015 Mar; 26(5):843-58. PubMed ID: 25540434
[TBL] [Abstract][Full Text] [Related]
33. Revisiting degron motifs in human AURKA required for its targeting by APC/C
Abdelbaki A; Ascanelli C; Okoye CN; Akman HB; Janson G; Min M; Marcozzi C; Hagting A; Grant R; De Luca M; Asteriti IA; Guarguaglini G; Paiardini A; Lindon C
Life Sci Alliance; 2023 Feb; 6(2):. PubMed ID: 36450448
[TBL] [Abstract][Full Text] [Related]
34. BRAF
Lauinger M; Christen D; Klar RFU; Roubaty C; Heilig CE; Stumpe M; Knox JJ; Radulovich N; Tamblyn L; Xie IY; Horak P; Forschner A; Bitzer M; Wittel UA; Boerries M; Ball CR; Heining C; Glimm H; Fröhlich M; Hübschmann D; Gallinger S; Fritsch R; Fröhling S; O'Kane GM; Dengjel J; Brummer T
Sci Adv; 2023 Sep; 9(35):eade7486. PubMed ID: 37656784
[TBL] [Abstract][Full Text] [Related]
35. Collapsing the Tumor Ecosystem: Preventing Adaptive Response to Treatment by Inhibiting Transcription.
Carugo A; Draetta GF
Cancer Discov; 2018 Jan; 8(1):17-19. PubMed ID: 29311224
[TBL] [Abstract][Full Text] [Related]
36. PRL-3 Promotes Ubiquitination and Degradation of AURKA and Colorectal Cancer Progression via Dephosphorylation of FZR1.
Zhang C; Qu L; Lian S; Meng L; Min L; Liu J; Song Q; Shen L; Shou C
Cancer Res; 2019 Mar; 79(5):928-940. PubMed ID: 30498084
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.
Zhang J; Bu X; Wang H; Zhu Y; Geng Y; Nihira NT; Tan Y; Ci Y; Wu F; Dai X; Guo J; Huang YH; Fan C; Ren S; Sun Y; Freeman GJ; Sicinski P; Wei W
Nature; 2018 Jan; 553(7686):91-95. PubMed ID: 29160310
[TBL] [Abstract][Full Text] [Related]
38. Anaphase-Promoting Complex Adaptor FZR1/CDH1 Blocks BRAF Signaling Both by Targeting BRAF for Proteolytic Degradation and by Disrupting BRAF Dimerization.
Zhang C; Bollag G
Cancer Discov; 2017 Apr; 7(4):356-358. PubMed ID: 28373167
[TBL] [Abstract][Full Text] [Related]
39. The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function.
Wan L; Chen M; Cao J; Dai X; Yin Q; Zhang J; Song SJ; Lu Y; Liu J; Inuzuka H; Katon JM; Berry K; Fung J; Ng C; Liu P; Song MS; Xue L; Bronson RT; Kirschner MW; Cui R; Pandolfi PP; Wei W
Cancer Discov; 2017 Apr; 7(4):424-441. PubMed ID: 28174173
[TBL] [Abstract][Full Text] [Related]
40. APC/C and retinoblastoma interaction: cross-talk of retinoblastoma protein with the ubiquitin proteasome pathway.
Ramanujan A; Tiwari S
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27402801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
